SKI Market

Indian Indices

Sensex

84,695.54 -345.91
( -0.41%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,388.37 -362.02
(-0.71%)

Nikkei 225

9,873.61 2.93
(0.03%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

126.56

28.25

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

NGL Fine Chem consolidated net profit declines 1.83% in the September 2025 quarter

Nov 13,2025

Net profit of NGL Fine Chem declined 1.83% to Rs 9.63 crore in the quarter ended September 2025 as against Rs 9.81 crore during the previous quarter ended September 2024. Sales rose 28.65% to Rs 120.26 crore in the quarter ended September 2025 as against Rs 93.48 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	120.26	93.48	29
OPM %	14.27	12.36	-
PBDT	18.05	16.36	10
PBT	12.96	13.33	-3
NP	9.63	9.81	-2

84,695.54 -345.91 ( -0.41%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,388.37 -362.02 (-0.71%)

9,873.61 2.93 (0.03%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)